FDA Inspection 1295306 - Bioreliance Corporation - January 29, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Bioreliance Corporation, with an inspection on January 29, 2026, issued by the Baltimore District Office, covering human drugs.

Company: Bioreliance Corporation
Inspection Date: January 29, 2026
Product Type: Human Drugs
Office: Baltimore District Office

Open in Dashboard

ID · e199758b-3727-437f-82a7-ea444bde9780

Violation Codes2

21 CFR 58.33(a)21 CFR 58.33(c)

Full citation text and observation details available on the Dashboard.